..., instructions or products referred to in the content or advertisements. 2024 Adrenocortical tumor Growth Final height Precocious puberty Adrenocortical tumors (ACTs) are rare in children and adolescents, accounting for less than 0.2% of all pediatric carcinomas. However, their incidence is 15...

... increase in height SDS at final height (FH) was significantly higher in GHD (2.21, CI: 2.00–2.42) compared to SGA (1.05, CI: 0.75–1.35) ( p < 0.001), leading to a target height corrected FH of −0.39 SDS (CI: −0.62 to −0.15) in GHD and −1.22 SDS (CI: −1.57 to −0.87) in SGA ( p < 0.001). Girls with GHD...

... androgens. Despite adequate replacement, impaired growth and overweight remain a clinical challenge. The main objective was to investigate the differences in growth, final height (FH), and body mass index (BMI) between different CYP21A2 genotype groups and glucocorticoid treatment strategies during...

... Turner syndrome Childhood Growth hormone Near-adult height Final height Thelarche Prepuberty Puberty Safety Data collected at Extension study baseline included historical information from the Inter-study period such as illnesses, GH and/or estrogen treatment, concomitant medications...

...Elodie Adler; Anne-Sophie Lambert; Claire Bouvattier; Cécile Thomas-Teinturier; Anya Rothenbuhler; Paul de Boissieu; Agnès Linglart Introduction: About 8% of children born small for gestational age (SGA) do not reach a final height within the normal range. Recombinant human growth hormone (rhGH...

... from mid-parental target height SDS [ 16 ] were evaluated. Growth hormone treatment Short stature Growth Safety Final height Growth failure and short stature in childhood are often early symptoms of an underlying disorder requiring appropriate diagnosis and management to achieve...

... infusion (CSII). Methods: One-hundred and four children (51 males) with prepubertal onset of T1DM were prospectively followed up to final height attainment. Results: Age at puberty onset was 11.7 ± 1.1 years in males and 10.9 ± 1.3 in females. Age at adult height attainment was 16.4 ± 1.6 years in males...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Turner syndrome Oxandrolone Growth hormone treatment Final height Guidelines While growth hormone (GH) has been shown to improve final height (FH) in Turner syndrome (TS), such treatment...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Final height Bone age advancement...

...Meropi Toumba; Assunta Albanese; Cristina Azcona; Richard Stanhope Background: The aim of this study was to determine the beneficial effects of long-term growth hormone (GH) treatment on final height (FH) in 26 children with Russell-Silver syndrome (RSS). Methods: Twenty-six patients (16 males...

... combined with growth hormone (GH) have been carried out. In a recent study 46 adopted girls with early or precocious puberty were randomly assigned to treatment with either GnRHa or GnRHa combined with GH, and followed to final height (FH). It was found that FH was significantly higher in the combined...

... mesomelic skeletal dysplasia. If untreated, short patients with SHOX deficiency remain short in adulthood. Growth hormone (GH) treatment improves short-term linear growth; however, there are no data on GH treatment effects on final height. Patients: In a retrospective study, we assessed the relative effects...

...M.D.C. Donaldson The effect of growth hormone (GH) on short-to-medium-term growth in girls with Turner syndrome is well-established. However, it is only relatively recently that final height data have become available. This paper reviews 10 reports from Europe (including Sweden, Austria, France...

...Jean-Claude Carel; Laurence Mathivon; Christine Gendrel; Jean-Louis Chaussain Growth hormone (GH) is registered for children with Turner syndrome (TS) in several countries. Improving the final heights (FH) is certainly the most worthy goal of therapy, but evaluation of treatment effect...

.... The other patient did not develop central puberty under ketoconazole treatment and improved his predicted adult height from 172.4 to 181.1 cm. Four patients reached final height [B.A. (therapy cyproterone acetate): age 22.0 years, -2.0 SDS; B.G. (untreated): age 15.5 years, -1.7 SDS; M.M. (therapy...

...Zvi Zadik; Amnon Zung Sixteen prepubertal children (10 males, 6 females) were treated with growth hormone (GH) 0.75 U/kg/week for 4-5 years until final height was attained. Before initiation of GH therapy height was below 2 SDS for age and gender, growth velocity was < 4.5 cm/year, bone age...

... Height prediction Final height TW2 method Bone Maturation Horm Ros I996;45(suppl 2):42^48 Lodovico Benso" Silvia Vannelli Lamberto Pastorin" Paride Angius" Silvano Milanih Centro di Auxologia, Università di Torino, Italy Istituto di Statistica M edicae Biometria. Università di Milano. Italy Main...

...A.M. Pasquino; F. Passeri; G. Municchi; M. Segni; I. Pucarelli; D. Larizza; G. Bossi; F. Severi; C. Galasso Growth hormone (GH), alone or in combination with anabolic steroids, seems to improve the growth rate in Turner syndrome, but to exert a less striking effect on the final height (FH). Reports...

...R. Kauli; A. Galatzer; L. Kornreich; L. Lazar; A. Pertzelan; Z. Laron This study was designed to determine the benefit of therapy on final height (FHt) in girls with central precocious puberty (CPP). A total of 102 patients were evaluated – 28 untreated, 26 treated with cyproterone acetate (CyA...

...B. Stasiowska; S. Vannelli; L. Benso Twenty-two girls affected by sexual precocity with impaired final height prognosis were followed until they achieved final height. Twelve of them were treated with an intranasal ( D -Ser 6 )-gonadotrophin-releasing hormone (GnRH) analogue (buserelin...